PLAU and neoplasm: When WX340 was administered after the tumours were allowed to first establish for 2 weeks, no inhibition of metastasis was observed (data not shown), indicating that uPA inhibition by WX340 specifically targets the progression of metastatic disease in the early stages of tumour development.